While it is generally recognised that corticotrophin and cortisone increase and diminish respectively the urinary excretion of neutral 17-ketosteroids (17-KS), the precise identity of the steroids, the excretion of which is mainly affected by these hormones, is still controversial (Forsham et al., 1948; Copeman et al., 1952; Louchart & Jailer, 1953 
It is thus difficult to obtain any standard pattern of neutral 17-KS excretion in these patients, as individual variation is so large, and the methods of in¬ vestigation often widely different.
The behaviour of cortisone treated patients is more constant, and a depres¬ sion of the total neutral 17-KS excretion has been observed by most workers in patients with a normal or initially high excretion (Copeman et al., 1952; Lou¬ chart Se Jailer, 1953) . A specific depression of the /?-fraction of a few patients with adrenal hyperplasia, and idiopathic hirsutism, both with and without elevated neutral 17-KS excretion, has been occasionally demonstrated during the administration of cortisone (Venning et al., 1952; Gardner, 1953; Louchait Se Jailer, 1953) . In patients with a normal total output of neutral 17-KS most investigators find a depression of all neutral 17-KS except the 1 l-oxy-17-ketosteroids, which may be breakdown products of the cortisone itself (Sprague et al, 1949) . PRESENT 
INVESTIGATION
The present material consists of the results from 12 patients treated with corti¬ sone or corticotrophin, in whom neutral 17-KS excretion has been followed be¬ fore, during and after therapy, by the estimation and microchromatographic fractionation of the urinary neutral 17-KS (Pond, 1951) . Discussion of the significance of the eight fractions has been previously published The effect of corticotrophin on the excretion of neutral 17-KS in patients free from endocrine disease was more variable (6-10). All these patients showed a combined rise of all fractions with selective rises of some. In no case was the /?-fraction raised outside the normal limits. In Case 10, the /j-fraction increased from 12-20°/o during therapy but returned to only 9°/o after cessation of treat¬ ment. There was little selective rise of the 11-oxy-l 7-ketosteroid fraction except in Case 9 and to a lesser extent 8. Cases 6 and 7 showed a relative rise of etio¬ cholanolone compared with androsterone.
The use of cortisone in patient 4 showed that adequate replacement therapy was taking place, with a rise of total neutral 17-KS, the rise being largely of the 11-oxy-l 7-ketosteroid fraction. The results of the endocrinologically normal patients so treated show that there is a depression of all fractions save the 1 l-oxy-17-ketosteroid fraction. The /5-fraction was not differentially depressed (11 & 12) .
DISCUSSION
In the patients in whom the initial adrenal function was greatly diminished, the effect of corticotrophin was striking and affected the two fractions common¬ ly associated with activity of the adrenal cortex, i. e., the /3-fraction and the 11-oxy-l 7-ketosteroid fraction. This agrees with the findings of previous workers, using patients with more normal adrenal function (Dingemanse Se -row 
